✦ LIBER ✦

Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: A 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial

✍ Scribed by Yeong Wook Song; Eun Young Lee; Eun-Mi Koh; Hoon-Suk Cha; Bin Yoo; Chang-Keun Lee; Han Joo Baek; Hyun Ah Kim; Young Suh II; Seong-Wook Kang; Yun Jong Lee; Hyung-gi Jung

Book ID: 116371973
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 861 KB
Volume: 29
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2007.05.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety profiles of a new S(

Efficacy and safety profiles of a new S(—)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial

✍ Sung Ai Kim; Sungha Park; Namsik Chung; Do-Sun Lim; Joo-Young Yang; Byung-Hee Oh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

✍ Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views

Efficacy and Tolerability of Fimasartan,

Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

✍ Sang Eun Lee; Yong-Jin Kim; Hae-Young Lee; Han-Mo Yang; Chang-Gyu Park; Jae-Joon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 806 KB

Results of a comparative, phase III, 12-

Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension

✍ Akhilesh Sharma; Ananda Bagchi; Satish B. Kinagi; Yogesh Kumar Sharma; Vidyagaur 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Comparison of the clinical efficacy and

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial

✍ J. Braun; P. Kästner; P. Flaxenberg; J. Währisch; P. Hanke; W. Demary; U. von Hi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 3 views

Safety and efficacy of ocrelizumab in pa

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial

✍ W. Rigby; H.-P. Tony; K. Oelke; B. Combe; A. Laster; C. A. von Muhlen; E. Fishel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views